Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
In Reply Thank you very much for the opportunity to reply to Mr Rosa and Dr Mohr. Their assertions are fundamentally flawed, rooted in mistaken assumptions, and unsupported by the peer-reviewed scientific data.
First, the data sets to which they refer—through imprecise and invalid extrapolations—are nonrepresentative, relatively small hospital populations drawn from voluntary quality improvement alliances1,2 and specific age groups (ie, Medicare).3 As such, they are susceptible to bias and unsuitable for inferring national trends in the diffusion of robotic surgery, particularly if a disproportionately large number of facilities participating in the quality improvement alliances own robotic surgery platforms. In contrast, we performed a cohort study of more than 400 000 patients using the much larger Nationwide Inpatient Sample, which the Agency for Healthcare Research and Quality designed to provide an appropriately weighted, representative sample of all US inpatient admissions.4
Parsons JK, Chang D. Faulty Analysis in Study of Robotic-Assisted Minimally Invasive Radical Prostatectomy—Reply. JAMA Surg. 2015;150(4):372. doi:10.1001/jamasurg.2015.45